# China’s rapid growth in early-stage pharma rattles US

Source: [Chemical & Engineering News: Latest News](https://cen.acs.org/policy/global-health/china-drug-pharamaceutical-research-clinical-trial/104/web/2026/11?sc=230901_cenrssfeed_eng_latestnewsrss_cen) · 2026-11-19 · Physics
Page: https://themorning.science/story/china-s-rapid-growth-in-early-stage-pharma-rattles-us-8dbec40353d2285a
Kind: business · Impact: medium

## In brief

- China is seeing a large increase in drug investment, drug discovery and clinical trials.
- The US faces research cuts, according to the source article.
- The source reports this shift in early-stage pharmaceutical research as a source of concern in the US.

## Why it matters

Shifts in where early-stage drug research and clinical trials happen can affect the pace of new medicines, research funding decisions and international collaboration in pharmaceutical science.

## Coverage

- [China’s rapid growth in early-stage pharma rattles US](https://cen.acs.org/policy/global-health/china-drug-pharamaceutical-research-clinical-trial/104/web/2026/11?sc=230901_cenrssfeed_eng_latestnewsrss_cen) — Chemical & Engineering News: Latest News, 2026-11-19

Tags: pharmaceuticals, drug discovery, clinical trials, research funding, china, us science policy

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
